A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy Females
Clinical trial NCT03126097 · TERMINATED
Trial details
- NCT number
- NCT03126097
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-13
- Primary completion
- 2017-05-26
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.